High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP
|ClinicalTrials.gov Identifier: NCT00451594|
Recruitment Status : Completed
First Posted : March 23, 2007
Last Update Posted : January 13, 2011
|Condition or disease||Intervention/treatment||Phase|
|Idiopathic Thrombocytopenic Purpura||Drug: Dexamethasone Drug: Prednisolone||Phase 3|
Patients will be randomized to one of two study arms:
dexamethasone 40 mg po daily for 4 consecutive days. If the platelet count drops below 30X109/L after response within 6 months, another four-day course of dexamethasone will be given, followed by 15 mg of prednisone daily, with gradual tapering (Arm 1).
Prednisone 1 mg/kg po daily for 4-8 weeks, the drug is then decreased slowly over another few weeks (Arm 2).
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||157 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Randomized Controlled Multicentre Trial of High Dose Dexamethasone Versus Conventional Dose Prednisolone for Adults With Untreated Idiopathic Thrombocytopenic Purpura|
|Study Start Date :||September 2005|
|Primary Completion Date :||December 2010|
|Study Completion Date :||December 2010|
- Patients will receive 40 mg of oral dexamethasone daily for four consecutive days.
- Other treatments should be considered if there was a platelet count of 30X109/L or less by day 14
- If the patient had a platelet count of more than 30X109/L after four days of dexamethasone treatment, no further treatment will be given.
- If the platelet count drops below 30X109/L within the first 6 months, another four-day course of dexamethasone will be given, followed by 15 mg of prednisone daily, with gradual tapering.
- Patients whose platelet counts can not be maintained at 30X109/L will be offered other treatments.
- Prednisone, 1 mg/kg is started at diagnosis. If the platelet count is more than 100X109/L, the dose should be used for 4 weeks minimally and then tapered by 10 mg/1 wk until the dose reaches 0.5 mg/kg of body weight and by 5 mg/1 wk thereafter. (Ann Intern Med 1997, 126, 307-14). If the platelet count is between 30X109/L and 100X109/L, prednisone 1 mg/kg should be used for 8 weeks maximally and then tapered by 10 mg/2 wk until the dose reaches 0.5 mg/kg of body weight and by 5 mg/2 wk thereafter.
- Guideline of prednisone tapering Duration of prednisone treatment: 3-6 months
Pulse high dose dexamethasone (Arm 1)
Conventional dose prednisone (Arm 2)
- response rate and platelet count [ Time Frame: 6 years ]Endpoint definitions and criteria for evaluation: This study is designed to compare the effectiveness of high dose dexamethasone with conventional dose prednisone for patient with ITP. The effectiveness will be evaluated in terms of response rate and platelet count at 6 months after the treatment
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00451594
|Korea, Republic of|
|Asan Medical Center|
|Seoul, Songpa-gu, Korea, Republic of, 138-736|
|Principal Investigator:||Sung Hwa Bae, professor||Daegu Catholic Univertity Hospital, ROK|
|Principal Investigator:||Jung-Hee Lee, professor||Asan Medical Center, ROK|